NewsBenzingaArcher-Daniels-Midland Expects 2027 Earnings To Be "Somewhere In The Range Of What 2026 Was, Plus/Minus A Little Bit" Archer-Daniels-Midland Expects 2027 Earnings To Be "Somewhere In The Range Of What 2026 Was, Plus/Minus A Little Bit" Benzinga 2026.11.03 14:17 (GMT+0) Open on Benzinga Other news Fermium Research Maintains Buy on DuPont de Nemours, Raises Price Target to $160 Morgan Stanley Maintains Equal-Weight on Allegion, Raises Price Target to $181 Morgan Stanley Maintains Overweight on Advanced Energy Indus, Lowers Price Target to $368 Oppenheimer Maintains Outperform on BioMarin Pharmaceutical, Lowers Price Target to $94 Truist Securities Reiterates Hold on V2X, Raises Price Target to $87 Anthropic is still grappling with the economics of compute
